{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:50Z","timestamp":1787020250128,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-03946-8","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:43:10Z","timestamp":1741754590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Retinal sensitivity above macular neovascularization under anti-VEGF therapy in exudative neovascular age-related macular degeneration"],"prefix":"10.1186","volume":"25","author":[{"given":"Laurenz","family":"Pauleikhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Bachmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Garcia","family":"Armendariz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3691-291X","authenticated-orcid":false,"given":"Daniel","family":"Pauleikhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"issue":"1","key":"3946_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12886-020-01554-2","volume":"20","author":"RP Finger","year":"2020","unstructured":"Finger RP, Daien V, Eldem BM, Talks JS, Korobelnik J-F, Mitchell P, et al. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration\u2013 a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems. BMC Ophthalmol. 2020;20(1):294.","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"3946_CR2","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ajo.2015.01.032","volume":"159","author":"RB Bhisitkul","year":"2015","unstructured":"Bhisitkul RB, Mendes TS, Rofagha S, Enanoria W, Boyer DS, Sadda SR, et al. Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP study. Am J Ophthalmol. 2015;159(5):915\u2013e9242.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"3946_CR3","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","volume":"123","author":"MG Maguire","year":"2016","unstructured":"Maguire MG, Martin DF, Ying G-S, Jaffe GJ, Daniel E, Grunwald JE, et al. Five-Year outcomes with Anti-Vascular endothelial growth factor treatment of neovascular Age-Related macular degeneration: the comparison of Age-Related macular degeneration treatments trials. Ophthalmology. 2016;123(8):1751\u201361.","journal-title":"Ophthalmology"},{"issue":"8","key":"3946_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.oret.2022.03.010","volume":"6","author":"T Peto","year":"2022","unstructured":"Peto T, Evans RN, Reeves BC, Harding S, Madhusudhan S, Lotery A, et al. Long-term retinal morphology and functional associations in treated neovascular Age-Related macular degeneration: findings from the Inhibition of VEGF in Age-Related choroidal neovascularisation trial. Ophthalmol Retina. 2022;6(8):664\u201375.","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"3946_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41433-022-02020-7","volume":"37","author":"D Rosenberg","year":"2023","unstructured":"Rosenberg D, Deonarain DM, Gould J, Sothivannan A, Phillips MR, Sarohia GS, et al. Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis. Eye (Lond). 2023;37(1):6\u201316.","journal-title":"Eye (Lond)"},{"issue":"9","key":"3946_CR6","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.ophtha.2015.05.010","volume":"122","author":"MC Gillies","year":"2015","unstructured":"Gillies MC, Campain A, Barthelmes D, Simpson JM, Arnold JJ, Guymer RH, et al. Long-Term outcomes of treatment of neovascular Age-Related macular degeneration: data from an observational study. Ophthalmology. 2015;122(9):1837\u201345.","journal-title":"Ophthalmology"},{"key":"3946_CR7","doi-asserted-by":"crossref","unstructured":"Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. The New England journal of medicine. 2006; 355(14). Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/17021319\/ [Accessed January 30, 2024].","DOI":"10.1056\/NEJMoa062655"},{"issue":"12","key":"3946_CR8","doi-asserted-by":"publisher","first-page":"e0288861","DOI":"10.1371\/journal.pone.0288861","volume":"18","author":"D Pauleikhoff","year":"2023","unstructured":"Pauleikhoff D, Gunnemann M-L, Ziegler M, Heimes-Bussmann B, Bormann E, Bachmeier I, et al. Morphological changes of macular neovascularization during long-term anti-VEGF-therapy in neovascular age-related macular degeneration. PLoS ONE. 2023;18(12):e0288861.","journal-title":"PLoS ONE"},{"issue":"6","key":"3946_CR9","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1177\/1120672120986370","volume":"31","author":"G Querques","year":"2021","unstructured":"Querques G, Sacconi R, Capuano V, Carnevali A, Colantuono D, Battista M, et al. Treatment-na\u00efve quiescent macular neovascularization secondary to AMD: the 2019 young investigator lecture of macula society. Eur J Ophthalmol. 2021;31(6):3164\u201376.","journal-title":"Eur J Ophthalmol"},{"key":"3946_CR10","doi-asserted-by":"publisher","first-page":"101113","DOI":"10.1016\/j.preteyeres.2022.101113","volume":"92","author":"R Sacconi","year":"2023","unstructured":"Sacconi R, Fragiotta S, Sarraf D, Sadda SR, Freund KB, Parravano M, et al. Towards a better Understanding of non-exudative choroidal and macular neovascularization. Prog Retin Eye Res. 2023;92:101113.","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"3946_CR11","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.ophtha.2020.01.040","volume":"127","author":"L Chen","year":"2020","unstructured":"Chen L, Messinger JD, Sloan KR, Swain TA, Sugiura Y, Yannuzzi LA, et al. Nonexudative macular neovascularization supporting outer retina in Age-Related macular degeneration: A clinicopathologic correlation. Ophthalmology. 2020;127(7):931\u201347.","journal-title":"Ophthalmology"},{"issue":"10","key":"3946_CR12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.oret.2022.04.012","volume":"6","author":"M Airaldi","year":"2022","unstructured":"Airaldi M, Corvi F, Cozzi M, Nittala MG, Staurenghi G, Sadda SR. Differences in Long-Term progression of atrophy between neovascular and nonneovascular Age-Related macular degeneration. Ophthalmol Retina. 2022;6(10):914\u201321.","journal-title":"Ophthalmol Retina"},{"issue":"2","key":"3946_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ophtha.2018.08.035","volume":"126","author":"GJ Jaffe","year":"2019","unstructured":"Jaffe GJ, Ying G-S, Toth CA, Daniel E, Grunwald JE, Martin DF, et al. Macular morphology and visual acuity in year five of the comparison of Age-related macular degeneration treatments trials (CATT). Ophthalmology. 2019;126(2):252\u201360.","journal-title":"Ophthalmology"},{"key":"3946_CR14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ajo.2020.11.002","volume":"223","author":"AP Finn","year":"2021","unstructured":"Finn AP, Pistilli M, Tai V, Daniel E, Ying G-S, Maguire MG, et al. Localized optical coherence tomography precursors of macular atrophy and fibrotic Scar in the comparison of Age-Related macular degeneration treatments trials. Am J Ophthalmol. 2021;223:338\u201347.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"3946_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1001\/jamaophthalmol.2020.3001","volume":"138","author":"RN Evans","year":"2020","unstructured":"Evans RN, Reeves BC, Maguire MG, Martin DF, Muldrew A, Peto T, et al. Associations of variation in retinal thickness with visual acuity and anatomic outcomes in eyes with neovascular Age-Related macular degeneration lesions treated with Anti-Vascular endothelial growth factor agents. JAMA Ophthalmol. 2020;138(10):1043\u201351.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"3946_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ophtha.2018.07.013","volume":"126","author":"C Bailey","year":"2019","unstructured":"Bailey C, Scott LJ, Rogers CA, Reeves BC, Hamill B, Peto T, et al. Intralesional macular atrophy in Anti-Vascular endothelial growth factor therapy for Age-Related macular degeneration in the IVAN trial. Ophthalmology. 2019;126(1):75\u201386.","journal-title":"Ophthalmology"},{"issue":"4","key":"3946_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, et al. Consensus definition for atrophy associated with Age-Related macular degeneration on OCT: classification of atrophy report 3. Ophthalmology. 2018;125(4):537\u201348.","journal-title":"Ophthalmology"},{"issue":"9900","key":"3946_CR18","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0140-6736(13)61501-9","volume":"382","author":"U Chakravarthy","year":"2013","unstructured":"Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Culliford LA, et al. Alternative treatments to inhibit VEGF in age-related choroidal XXXandomizedXXXization: 2-year findings of the IVAN XXXandomized controlled trial. Lancet. 2013;382(9900):1258\u201367.","journal-title":"Lancet"},{"issue":"1","key":"3946_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/tvst.8.1.7","volume":"8","author":"L n der Emde","year":"2019","unstructured":"n der Emde L, Pfau M, Thiele S, M\u00f6ller PT, Hassenrik R, Fleckenstein M, et al. Mesopic and Dark-Adapted Two-Color Fundus-Controlled perimetry in choroidal neovascularization secondary to Age-Related macular degeneration. Transl Vis Sci Technol. 2019;8(1):7.","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"3946_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41433-023-02652-3","volume":"38","author":"M Cozzi","year":"2023","unstructured":"Cozzi M, Monteduro D, Esposito RA, Spooner KL, Fraser-Bell S, Staurenghi G, et al. Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen. Eye (Lond). 2023;38(1):161\u20137.","journal-title":"Eye (Lond)"},{"issue":"5","key":"3946_CR21","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","volume":"127","author":"RF Spaide","year":"2020","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, et al. Consensus nomenclature for reporting neovascular Age-Related macular degeneration data: consensus on neovascular Age-Related macular degeneration nomenclature study group. Ophthalmology. 2020;127(5):616\u201336.","journal-title":"Ophthalmology"},{"issue":"7","key":"3946_CR22","doi-asserted-by":"publisher","first-page":"e0271543","DOI":"10.1371\/journal.pone.0271543","volume":"17","author":"R Ozawa","year":"2022","unstructured":"Ozawa R, Azuma K, Nomura Y, Murata H, Asaoka R, Kitamoto K, et al. Association between retinal sensitivity and the presence of quiescent choroidal neovascularization in pachychoroid diseases. PLoS ONE. 2022;17(7):e0271543.","journal-title":"PLoS ONE"},{"issue":"4","key":"3946_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000517187","volume":"244","author":"T Nizawa","year":"2021","unstructured":"Nizawa T, Kitahashi M, Baba T, Iwase T, Kubota-Taniai M, Hattori Y, et al. Improvements of retinal sensitivity after intravitreal injection of Aflibercept in eyes with neovascular Age-Related macular degeneration with or without polypoidal choroidal vasculopathy. Ophthalmologica. 2021;244(4):347\u201360.","journal-title":"Ophthalmologica"},{"issue":"2","key":"3946_CR24","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1167\/iovs.12-11046","volume":"54","author":"F Sulzbacher","year":"2013","unstructured":"Sulzbacher F, Kiss C, Kaider A, Roberts P, Munk M, Kroh ME, et al. Correlation of OCT characteristics and retinal sensitivity in neovascular age-related macular degeneration in the course of monthly Ranibizumab treatment. Invest Ophthalmol Vis Sci. 2013;54(2):1310\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3946_CR25","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1167\/iovs.14-14298","volume":"56","author":"F Sulzbacher","year":"2014","unstructured":"Sulzbacher F, Roberts P, Munk MR, Kaider A, Kroh ME, Sacu S, et al. Relationship of retinal morphology and retinal sensitivity in the treatment of neovascular age-related macular degeneration using Aflibercept. Invest Ophthalmol Vis Sci. 2014;56(2):1158\u201367.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3946_CR26","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s00347-013-2883-1","volume":"111","author":"S Bartels","year":"2014","unstructured":"Bartels S, Barrelmann A, Book B, Heimes B, Gutfleisch M, Spital G, et al. [Tear in retinal pigment epithelium under anti-VEGF therapy for exudative age-related macular degeneration: function recovery under intensive therapy]. Ophthalmologe. 2014;111(5):460\u20134.","journal-title":"Ophthalmologe"},{"issue":"7","key":"3946_CR27","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/eye.2017.34","volume":"31","author":"E Midena","year":"2017","unstructured":"Midena E, Pilotto E. Microperimetry in age: related macular degeneration. Eye (Lond). 2017;31(7):985\u201394.","journal-title":"Eye (Lond)"},{"issue":"3","key":"3946_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.survophthal.2019.01.014","volume":"64","author":"KG Csaky","year":"2019","unstructured":"Csaky KG, Patel PJ, Sepah YJ, Birch DG, Do DV, Ip MS, et al. Microperimetry for geographic atrophy secondary to age-related macular degeneration. Surv Ophthalmol. 2019;64(3):353\u201364.","journal-title":"Surv Ophthalmol"},{"key":"3946_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2147\/OPTH.S151999","volume":"12","author":"H Takahashi","year":"2018","unstructured":"Takahashi H, Inoue Y, Tan X, Inoda S, Sakamoto S, Arai Y, et al. Visual acuity loss associated with excessive \u2018dry macula\u2019 in exudative age-related macular degeneration. Clin Ophthalmol. 2018;12:369\u201375.","journal-title":"Clin Ophthalmol"},{"key":"3946_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ajo.2016.05.007","volume":"168","author":"AH Hariri","year":"2016","unstructured":"Hariri AH, Tepelus TC, Akil H, Nittala MG, Sadda SR. Retinal sensitivity at the junctional zone of eyes with geographic atrophy due to Age-Related macular degeneration. Am J Ophthalmol. 2016;168:122\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3946_CR31","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1167\/iovs.10-6075","volume":"52","author":"AD Meleth","year":"2011","unstructured":"Meleth AD, Mettu P, Agr\u00f3n E, Chew EY, Sadda SR, Ferris FL, et al. Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry. Invest Ophthalmol Vis Sci. 2011;52(2):1119\u201326.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-03946-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:43:14Z","timestamp":1741754594000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-03946-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3946"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-03946-8","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"18 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics committee of Westfalia\/Germany (2017-033-f-S).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to participate and results to be published: informed consent to participate was obtained from all of the participants in the study (approved by the Institutional Ethics committee of Westfalia\/Germany).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}